Drug Dosing: Geriatric Patients
Kubler Ross's Stages of Dying
Pharmacodynamics in Geriatric Patients: Effects of Age
Actuarial Approach
Life Tables
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 8, 2026

Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans
Published on: May 18, 2022
Álvaro Sanz Rubiales1, María Luisa Del Valle Rivero2, Lucía Mateo Otero3
1Hospital Universitario del Río Hortega. Valladolid. asrubiales@hotmail.com.
Professor Emanuel will refuse non-palliative treatments after 75, citing quality of life and family burden. His decision, while stoic, raises bioethical questions about utilitarianism and individualism in end-of-life care.
Area of Science: